Jade M. van Berge Henegouwen

The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

Daphne van der Velden, Louisa R. Hoes, Hanneke van der Wijngaart et al. · Nature · 2019 · 252 citations · Full text

Drug Repositioning, Oncology, Preclinical Drug Evaluation +11

Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

Louisa R. Hoes, Jade M. van Berge Henegouwen, Hanneke van der Wijngaart et al. · Clinical Cancer Research · 2022 · 79 citations · Full text

Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer

Jade M. van Berge Henegouwen, M. Jebbink, Louisa R. Hoes et al. · European Journal of Cancer · 2022 · 21 citations · Full text

Medicine, Pathology, Pertuzumab Combination Therapy +6

Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin<scp>D‐CDK4</scp>/6 pathway alterations in the Dutch<scp>DRUP</scp>and Australian<scp>MoST</scp>trials

Laurien J. Zeverijn, Eleonora J. Looze, Subotheni Thavaneswaran et al. · International Journal of Cancer · 2023 · 19 citations · Full text

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

Birgit S. Geurts, Thomas Battaglia, Jade M. van Berge Henegouwen et al. · BMC Cancer · 2023 · 12 citations · Full text